Iradimed Corp. (IRMD) Tops Q4 EPS by 1c

Iradimed Corp. (NASDAQ: IRMD) reported Q4 EPS of $0.39, $0.01 better than the analyst estimate of $0.38. Revenue for the quarter came in at $17.5 million versus the consensus estimate of $17 million.

For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
• Piper Sandler on Fervo Energy (FRVO): 'Capital Access Supports Potential Upside'